Health Services Administration

Search results

• Arvinas gains 24% in past year

  John M Young

  7/10/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $24.63) falls a second month, trailing 80% of stocks

  John M Young

  1/10/24

  1 item of Media coverage

  Press/Media

• Arvinas plummets 40% in 2024, underperforming 87% of its global peers

  John M Young

  13/09/24

  1 item of Media coverage

  Press/Media

• Arvinas dips 4% in past year

  John M Young

  3/09/24

  2 items of Media coverage

  Press/Media

• Arvinas tumbles 36% in 2024

  John M Young

  3/09/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $26.16) sinks 5%, trailing 82% of stocks

  John M Young

  30/08/24

  1 item of Media coverage

  Press/Media

• Arvinas tumbles 39% in 2024

  John M Young

  9/08/24

  1 item of Media coverage

  Press/Media

• Arvinas increases 11% in past year

  John M Young

  5/08/24

  1 item of Media coverage

  Press/Media

• Arvinas tumbles 33% in 2024

  John M Young

  5/08/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $27.51) rises 3% on high volatility in July 2024

  John M Young

  1/08/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $27.51) rises 3% on high volatility in July 2024

  John M Young

  31/07/24

  1 item of Media coverage

  Press/Media

• Arvinas tumbles 30% in 2024

  John M Young

  12/07/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $26.62) drops 20% on high volatility in June 2024

  John M Young

  1/07/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $26.62) drops 20% on high volatility in June 2024

  John M Young

  28/06/24

  1 item of Media coverage

  Press/Media

• Arvinas tumbles 36% in 2024

  John M Young

  14/06/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $33.14) jumps 4%, beating 85% of stocks

  John M Young

  31/05/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $31.77) falls for a second consecutive month, a two-month fall of 31%

  John M Young

  1/05/24

  1 item of Media coverage

  Press/Media

• Empowering Professionals, Enhancing Care: Highlights From Day Three at Military Health System Conference

  Beth Hawks, Steven Durning, Danielle Holt, Paul Pasqina & Lynette Hamlin

  19/04/24

  1 item of Media coverage

  Press/Media

• Recent Findings in Opioids Described by Researchers from Uniformed Services University of the Health Sciences (Prenatal opioid use as a predictor of postpartum suicide attempts among reproductive-age women enrolled in Oregon Medicaid)

  Jangho Yoon & Patrick Richard

  11/04/24

  1 item of Media coverage

  Press/Media

• Arvinas Compendium - A Snapshot as of March 31, 2024

  John M Young

  1/04/24

  2 items of Media coverage

  Press/Media

• Arvinas Compendium - A Snapshot as of March 31, 2024

  John M Young

  1/04/24

  1 item of Media coverage

  Press/Media

• Prenatal opioid use as a predictor of postpartum suicide attempts among reproductive-age women enrolled in Oregon Medicaid

  Jangho Yoon & Patrick Richard

  25/03/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $45.98) up 25%, 2 months' volume in a month

  John M Young

  4/03/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $45.98) soars 25%, 2 months' volume in a month

  John M Young

  1/03/24

  1 item of Media coverage

  Press/Media

• Monthly: Arvinas (ARVN: $45.98) up 25%, 2 months' volume in a month

  John M Young

  29/02/24

  1 item of Media coverage

  Press/Media